KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hims & Hers Health (HIMS) Shares Outstanding (Weighted Average): 2019-2024

Historic Shares Outstanding (Weighted Average) for Hims & Hers Health (HIMS) over the last 6 years, with Dec 2024 value amounting to $218.5 million.

  • Hims & Hers Health's Shares Outstanding (Weighted Average) rose 4.12% to $226.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $226.0 million, marking a year-over-year increase of 4.12%. This contributed to the annual value of $218.5 million for FY2024, which is 3.06% up from last year.
  • According to the latest figures from FY2024, Hims & Hers Health's Shares Outstanding (Weighted Average) is $218.5 million, which was up 3.06% from $212.0 million recorded in FY2023.
  • Hims & Hers Health's Shares Outstanding (Weighted Average)'s 5-year high stood at $218.5 million during FY2024, with a 5-year trough of $25.2 million in FY2020.
  • Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $212.0 million (2023), whereas its average is $212.7 million.
  • Data for Hims & Hers Health's Shares Outstanding (Weighted Average) shows a peak YoY soared of 710.59% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Hims & Hers Health's Shares Outstanding (Weighted Average) stood at $25.2 million in 2020, then skyrocketed by 710.59% to $203.9 million in 2021, then increased by 1.88% to $207.7 million in 2022, then grew by 2.05% to $212.0 million in 2023, then climbed by 3.06% to $218.5 million in 2024.